[go: up one dir, main page]

CA2627364A1 - Materiaux de matrice extracellulaire comme adjuvant de vaccin pour des maladies liees a des toxines ou a des agents pathogenes infectueux - Google Patents

Materiaux de matrice extracellulaire comme adjuvant de vaccin pour des maladies liees a des toxines ou a des agents pathogenes infectueux Download PDF

Info

Publication number
CA2627364A1
CA2627364A1 CA002627364A CA2627364A CA2627364A1 CA 2627364 A1 CA2627364 A1 CA 2627364A1 CA 002627364 A CA002627364 A CA 002627364A CA 2627364 A CA2627364 A CA 2627364A CA 2627364 A1 CA2627364 A1 CA 2627364A1
Authority
CA
Canada
Prior art keywords
infectious pathogen
vaccine
adjuvant
extracellular matrix
interest
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002627364A
Other languages
English (en)
Inventor
Mark A. Suckow
William R. Wolter
Paul Hall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cook Biotech Inc
University of Notre Dame
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/699,448 external-priority patent/US9308252B2/en
Application filed by Individual filed Critical Individual
Publication of CA2627364A1 publication Critical patent/CA2627364A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne des vaccins et des adjuvants de vaccin utiles dans le traitement et/ou la prévention d'infections et de maladies associées à des agents pathogènes infectieux, tels que le tétanos, ainsi que des maladies associées à des toxines biologiques. L'invention concerne en outre des procédés de préparation d'un adjuvant et du vaccin contenant l'adjuvant. Des procédés sont également fournis pour vacciner/immuniser un animal contre une infection et des maladies associées à des agents pathogènes infectieux, tels que le tétanos, et contre d'autres maladies associées à des toxines biologiques. L'invention concerne également des matériaux d'adjuvants préparés à partir d'un matériau de matrice extracellulaire. Il a été prouve que les adjuvants améliorent l'immunogénicité d'un antigène d'agent pathogène infectieux ou d'un antigène de toxine biologique d'intérêt et donc la survie d'un animal immunisé.
CA002627364A 2007-01-30 2007-05-25 Materiaux de matrice extracellulaire comme adjuvant de vaccin pour des maladies liees a des toxines ou a des agents pathogenes infectueux Abandoned CA2627364A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/699,448 US9308252B2 (en) 2005-10-27 2007-01-30 Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
US11/699,448 2007-01-30
PCT/US2007/069727 WO2008094276A1 (fr) 2007-01-30 2007-05-25 Matériaux de matrice extracellulaire comme adjuvants de vaccin contre des maladies associées à des agents pathogènes infectieux ou à des toxines

Publications (1)

Publication Number Publication Date
CA2627364A1 true CA2627364A1 (fr) 2008-07-30

Family

ID=39671610

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002627364A Abandoned CA2627364A1 (fr) 2007-01-30 2007-05-25 Materiaux de matrice extracellulaire comme adjuvant de vaccin pour des maladies liees a des toxines ou a des agents pathogenes infectueux

Country Status (1)

Country Link
CA (1) CA2627364A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8257715B1 (en) 2004-08-26 2012-09-04 University Of Notre Dame Tissue vaccines and uses thereof
US8778360B2 (en) 2005-10-27 2014-07-15 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US8802113B2 (en) 2005-10-27 2014-08-12 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US9308252B2 (en) 2005-10-27 2016-04-12 Cook Biotech, Inc. Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
CN110665001A (zh) * 2019-11-14 2020-01-10 上海农林职业技术学院 一种水性复合佐剂、其应用及猫用疫苗

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8257715B1 (en) 2004-08-26 2012-09-04 University Of Notre Dame Tissue vaccines and uses thereof
US8778360B2 (en) 2005-10-27 2014-07-15 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US8802113B2 (en) 2005-10-27 2014-08-12 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US9308252B2 (en) 2005-10-27 2016-04-12 Cook Biotech, Inc. Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
CN110665001A (zh) * 2019-11-14 2020-01-10 上海农林职业技术学院 一种水性复合佐剂、其应用及猫用疫苗

Similar Documents

Publication Publication Date Title
US9308252B2 (en) Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
JP2011190278A (ja) 粘膜体表面に接触させてワクチン抗原を包含する物質の効果を調節する新規非抗原性粘膜アジュバント処方
US9585955B2 (en) Lipid and nitrous oxide combination as adjuvant for the enhancement of the efficacy of vaccines
US8277778B2 (en) Vaccine adjuvants
CA2627364A1 (fr) Materiaux de matrice extracellulaire comme adjuvant de vaccin pour des maladies liees a des toxines ou a des agents pathogenes infectueux
US10293041B2 (en) Multivalent stable vaccine composition and methods of making same
US20140322272A1 (en) Vaccine
AU2004235815A1 (en) Vaccinating against infectious diseases using proteosomes
Gomez et al. Vaccine Section 4 manufacturing
Vogel et al. Immunologic Section 1: General 5 adjuvants
HK1118013B (en) Lipid and nitrous oxide combination as adjuvant for the enhancement of the efficacy of vaccines

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20160104